Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
about
The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosaRole of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potentialThe kallikrein-kinin system in diabetic nephropathyRole of plasma kallikrein in diabetes and metabolismAttenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitorsMetabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IIRole of bradykinin B1 and B2 receptors in normal blood pressure regulationUpregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic ratsAT2 Receptors: Potential Therapeutic Targets for Hypertension.The angiotensin II type 2 receptor and the kidney.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureAT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionInteraction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease.Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta.Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cellsHypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice.Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Nonclassical renin-angiotensin system and renal function.Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation.Therapeutic potential of angiotensin II receptor antagonists.Angiotensin II receptors and drug discovery in cardiovascular disease.Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.Angiotensin AT2 receptors: cardiovascular hope or hype?Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideDifferential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta.AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.Angiotensin type 2 receptor (AT2R): a challenging twin.The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Challenges posed to the maternal circulation by pregnancy
P2860
Q21093338-3625AAA7-6E28-43A4-B9AE-EB24D632FC98Q26825135-48BEB7AE-5F1C-4177-AD33-E0CD35612D0BQ26827473-68D0F7C5-F092-4CD1-90A3-4BC7B4FEEECDQ27016431-80AD0F0D-5F87-43E4-B0F5-51CC7618A865Q27346365-40650A76-85B2-464A-8B76-0981AACF8A25Q28077454-5C51B197-7013-4A46-AED8-29344CBF2D08Q28218830-F3D54977-39B0-4DC2-AB57-94D8C75B8DFDQ28390079-2FA897E2-2071-4458-818E-49A46CCDB502Q28508911-35C1B291-73F6-4F35-8F39-5BC80D5D6DCBQ28573751-F140FBBA-A9D0-4205-B79D-9ABD4755A25AQ28580814-31569088-8F28-4D7C-A0B7-E0B84A510EAEQ30275852-F4E475E8-4AE8-409C-AD59-901B1BAD779FQ30413945-75AA9BA1-9664-4502-BFB2-12B5C1B65927Q30414541-D1A4FDE4-9543-4BA1-A910-EDD99DEAFE83Q30415577-28F54701-F2C3-4E21-8D61-E0C4C38540E2Q30444722-31259226-00E8-4BCA-B8F4-2E36ADAD3591Q31115399-BC77CCE6-C6DE-4CD1-8432-E76C29FA2588Q33655956-D5D3860F-5557-42C9-9965-62E0DC512B23Q33685969-B92F8A9D-E22F-4797-A932-19A03A12E763Q33760484-7D6C5539-A5EB-4C80-9978-21327F4F9F2AQ33782669-8D2551B6-E2D8-4F30-9E1C-B3A48E9E1902Q33881270-1B7E1713-F96B-46AB-89E4-7BB1D60623DBQ33928318-39A6EC72-80F5-416F-AFE6-94CC4716AAA4Q34075614-DC9B03FE-FF04-49D1-BC82-4450B901C42AQ34177503-C2B766A9-6FCE-4E97-A6C2-17D83A13D6CAQ34238307-63DE9D97-9179-4EEE-8E30-67DF1FD6B831Q34293723-0819DF9C-521C-428D-85AA-CDDA51C180B5Q34369972-1CD9045A-F265-40F0-AAAC-CCC6009CDE7AQ34481715-4615162A-7490-46C5-B099-A168B385E85AQ34496676-A30D0942-E60B-412B-9BAF-25D6AD114E60Q34700791-A457E17E-007D-484A-B583-763B5C5A3FA1Q35045801-75493192-18A9-471A-B9AC-DD1D4F31183BQ35045808-F123D1D7-B50A-4789-AF1E-62AF980763E6Q35046246-1CBC3E07-10AE-4A82-9069-9FD91CCC1726Q35047332-DA6CEC76-A42A-444A-95F0-4167C7225D52Q35064653-14ECE930-8583-40F2-8875-A083E7AEDF69Q35122620-1A328701-686A-414C-A251-29993CF0301BQ35148421-D59CB0E7-853A-4A48-93AC-4005937B9A61Q35251166-CC0B5BFB-2175-48D1-988C-7E5ABA5674FAQ35602490-AB520C44-D6D1-4D1F-9F40-FF790342FB53
P2860
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Angiotensin II type 2 receptor ...... system and causes vasodilation
@en
type
label
Angiotensin II type 2 receptor ...... system and causes vasodilation
@en
prefLabel
Angiotensin II type 2 receptor ...... system and causes vasodilation
@en
P2093
P2860
P356
P1476
Angiotensin II type 2 receptor ...... system and causes vasodilation
@en
P2093
A Fujiyama
H Kurihara
H Matsubara
H Takahashi
K Nakagawa
M Miyazaki
S Fujiyama
P2860
P304
P356
10.1172/JCI7886
P407
P577
1999-10-01T00:00:00Z